DOXAZOSIN AS A TREATMENT FOR POST TRAUMATIC STRESS SYNDROME

Trial Profile

DOXAZOSIN AS A TREATMENT FOR POST TRAUMATIC STRESS SYNDROME

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jul 2017

At a glance

  • Drugs Doxazosin (Primary) ; Perindopril
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 May 2016 Primary endpoint of change in Clinician-Administered PTSD Scale (CAPS17) scores has not been met, according to results published in the Journal of Clinical Psychiatry.
    • 01 May 2016 Primary endpoint of posttraumatic stress disorder (PTSD) Checklist (PCL) (m) ratings has been met, according to results published in the Journal of Clinical Psychiatry.
    • 01 May 2016 Results published in the Journal of Clinical Psychiatry
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top